Cargando…

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue

Recently, there has been a substantial increase in the number of studies focused upon connecting the gut microbiome with cases of central nervous system (CNS) autoimmunity. Multiple sclerosis (MS) is a neurodegenerative autoimmune disorder of the CNS. Recent experimental and clinical evidence sugges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirby, Trevor O., Ochoa-Repáraz, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163724/ https://www.ncbi.nlm.nih.gov/pubmed/30149548 http://dx.doi.org/10.3390/medsci6030069

Ejemplares similares

Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis
por: Hoffman, Kristina, et al.
Publicado: (2023)

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?
por: Kohl, Hannah M., et al.
Publicado: (2020)

Gut microbiome and the risk factors in central nervous system autoimmunity
por: Ochoa-Repáraz, Javier, et al.
Publicado: (2014)

Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
por: Benedict, Ralph H B, et al.
Publicado: (2020)

Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
por: Roberts, Bradley, et al.
Publicado: (2022)

Gut microbiome in systemic sclerosis: a potential therapeutic target
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2020)

Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
por: Maglione, Alessandro, et al.
Publicado: (2021)

The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders
por: Dunalska, Anna, et al.
Publicado: (2023)

The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
por: Kim, Suhee, et al.
Publicado: (2022)

Gut Dysbiosis: A New Avenue for Stroke Prevention and Therapeutics
por: Park, Shin Young, et al.
Publicado: (2023)

Editorial: The Role of the Gut Microbiota in Health and Inflammatory Diseases
por: Mangalam, Ashutosh K., et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

Alterations of the human gut microbiome in multiple sclerosis
por: Jangi, Sushrut, et al.
Publicado: (2016)

The Role of Diet and Gut Microbiome in Multiple Sclerosis
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

Feeding the gut microbiome: impact on multiple sclerosis
por: Bronzini, Matteo, et al.
Publicado: (2023)

Multiple sclerosis and the microbiota: Progress in understanding the contribution of the gut microbiome to disease
por: Engelenburg, Hendrik J, et al.
Publicado: (2022)

New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
por: Lorente-Picón, Marina, et al.
Publicado: (2021)

Multiple Sclerosis and Microbiome
por: Preiningerova, Jana Lizrova, et al.
Publicado: (2022)

Senescence and the SASP: many therapeutic avenues
por: Birch, Jodie, et al.
Publicado: (2020)

Therapeutic avenues for γδ T cells in cancer
por: Costa, Gonçalo Palrão, et al.
Publicado: (2023)

Exploring the diversity of blood microbiome during liver diseases: Unveiling Novel diagnostic and therapeutic Avenues
por: Vasudevan, Dinakaran, et al.
Publicado: (2023)

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues
por: Singh, Rajan, et al.
Publicado: (2021)

Glycosphingolipids and Infection. Potential New Therapeutic Avenues
por: Aerts, Johannes M. F. G., et al.
Publicado: (2019)

Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy
por: Yadav, Sudhir Kumar, et al.
Publicado: (2023)

The Gut–Brain Axis as a Therapeutic Target in Multiple Sclerosis
por: Buga, Ana Maria, et al.
Publicado: (2023)

An update on Cryptosporidium biology and therapeutic avenues
por: Dhal, Ajit Kumar, et al.
Publicado: (2022)

Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications
por: Wang, Xu, et al.
Publicado: (2022)

Gut microbiome is associated with multiple sclerosis activity in children
por: Horton, Mary K., et al.
Publicado: (2021)

Alterations of host-gut microbiome interactions in multiple sclerosis
por: Cantoni, Claudia, et al.
Publicado: (2022)

A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders
por: Ochoa-Repáraz, Javier, et al.
Publicado: (2020)

Senescence and aging: Causes, consequences, and therapeutic avenues
por: McHugh, Domhnall, et al.
Publicado: (2018)

Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers
por: Sun, Hui-Yan, et al.
Publicado: (2022)

Tumor Necrosis Factor Alpha Blockade and Multiple Sclerosis: Exploring New Avenues
por: Zahid, Maryam, et al.
Publicado: (2021)

Gut microbiome in multiple sclerosis: The players involved and the roles they play
por: Shahi, Shailesh K., et al.
Publicado: (2017)

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
por: Reynders, Tatjana, et al.
Publicado: (2020)

The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle
por: Elsayed, Noha S., et al.
Publicado: (2022)

Extracellular Vesicles and Acute Kidney Injury: Potential Therapeutic Avenue for Renal Repair and Regeneration
por: Kosanović, Maja, et al.
Publicado: (2022)

Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues
por: Liang, Junyi, et al.
Publicado: (2023)

Helminth Induced Immunoregulation and Novel Therapeutic Avenue of Allergy
por: Ayelign, Birhanu, et al.
Publicado: (2020)

New Promising Therapeutic Avenues of Curcumin in Brain Diseases
por: Benameur, Tarek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9req3fsj3s89ah13ghci05f9js